• Explore /
  • Poster
  • / Impact of the influenza vaccination on cancer patients undergoing therapy with immune checkpoint inhibitors (ICI).

Impact of the influenza vaccination on cancer patients undergoing therapy with immune checkpoint inhibitors (ICI).

Abstract Poster

Authors

Ragisha Gopalakrishnan

Ragisha Gopalakrishnan

Vanderbilt University Medical Center, Nashville, TN

Ragisha Gopalakrishnan , Douglas Buckner Johnson , Sally York , Michael N. Neuss , Travis John Osterman , David D. Chism , Kristin Kathleen Ancell , Ingrid A. Mayer , Vandana Gupta Abramson , Mia Alyce Levy , Kenneth Wyman , Jill Gilbert , Nishita Reddy , David S. Morgan , Kimryn Rathmell , Leora Horn

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics and Translational Research

Sub Track

Cellular Immunotherapy

Citation

J Clin Oncol 36, 2018 (suppl; abstr 3053)

DOI

10.1200/JCO.2018.36.15_suppl.3053

Abstract #

3053

Poster Bd #

267

Abstract Disclosures

Similar Posters

First Author: Mengni Guo

Poster

2024 ASCO Genitourinary Cancers Symposium

Atezolizumab plus personalized neoantigen vaccination (PGV001) in patients with urothelial cancer.

Atezolizumab plus personalized neoantigen vaccination (PGV001) in patients with urothelial cancer.

First Author: Jonathan Forrest Anker

First Author: Can Aydogdu

First Author: Derek Huang